Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge in demand for alternative options to traditional mental health support have fueled interest and curiosity in the burgeoning field of psychedelic-assisted therapy. Mounting evidence … Continue reading “Psychedelics to Alter $2.5 Trillion Mental Health Market”
